Scientists Parlay Youth into Top French Jobs

Volume 16 | Issue 13 | 42 | Jun. 24, 2002 Previous | Next Scientists Parlay Youth into Top French Jobs Sluggish reform in France's rigid tenure systems assuages some young researchers | By Clare Kittredge Image: Getty Images Dana Philpott enjoys rare success among scientists in their thirties in France. Many French postdoctoral trainees leave the country to do research and return home only to

Written byClare Kittredge
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

Dana Philpott enjoys rare success among scientists in their thirties in France. Many French postdoctoral trainees leave the country to do research and return home only to work in someone else's laboratory. But only six years after obtaining her PhD from the University of Toronto, Philpott, 35, directs her own lab at the Pasteur Institute in the posh 15th arrondissement of Paris. There, she researches Nod1, a protein found in humans, plants, and fish, which recognizes bacteria and lets its host respond and clear infection.

Philpott is among a handful of researchers in France taking advantage of innovations in that country's pyramidal scientific research system. In the United States, postdocs can often look forward to getting an assistant professorship, where they will be expected to build a research group, find funding for salaries, and publish scientific papers. If they succeed they can usually make tenure.

By contrast, in France, tenured ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies